Record Revenue Achieved
Product revenue reached a record $9.2 million, an 83% increase compared to the same period in 2023.
Significant Growth in Medicare Part B Patients
Revenue from Medicare Part B patients accounted for 55% of product revenue, up from 47% in the previous quarter, reflecting successful outreach and education efforts.
Expansion of O&P Channel
Successfully trained over 100 clinicians by the end of the year, surpassing the set goal. O&P channel activity is expected to increase in 2025.
Strong International Revenue
International operations, particularly in Germany, generated a record $1.1 million in revenue, representing 12% of the total.
Backlog and Pipeline Growth
Record backlog of 316 units and a pipeline of 1,263 patients, a 21% increase year-over-year.
Positive Progress with Payers
Entered contracts with Blue Cross Blue Shield of Massachusetts and Paradigm, covering 3 million lives.